Zhejiang Realsun Chemical Co., Ltd. is a China-based company primarily engaged in the research, development, production, and distribution of specialty fine chemicals, pharmaceutical intermediates, agrochemical intermediates, and electronic chemical materials. Founded in 2007 and headquartered in Linhai, Zhejiang Province, China, the company operates advanced production bases and research facilities supplying customers across domestic and international markets, including Europe, North America, and other regions in Asia. The company's core product portfolio encompasses cyclopropane derivatives, including cyclopropanecarbonyl chloride, cyclopropanecarboxylic acid, cyclopropyl methyl ketone, and cyclopropylamine; butyryl and isobutyryl derivatives, including isobutyryl chloride and isobutyric anhydride; pyrrolidone and lactone series chemicals, including gamma-butyrolactone (GBL), N-methyl-2-pyrrolidone (NMP), and 2-pyrrolidone derivatives; boron trifluoride complexes and specialized Lewis acid catalysts; high-purity pharmaceutical intermediates for antiviral, antibacterial, oncology, cardiovascular, and central nervous system drug therapies; active agrochemical intermediates applied in novel fungicides, herbicides, and insecticides; electronic-grade specialty solvents and functional additives for electronic manufacturing; and custom synthesis and contract development and manufacturing organization (CDMO) services for global chemical and life sciences enterprises. In recent developments, Zhejiang Realsun Chemical has advanced the construction and commissioning of high-end fine chemical and electronic chemical manufacturing capacities, expanded continuous flow and micro-channel reaction technologies across its production lines to enhance operational efficiency and environmental compliance, diversified its product pipeline into high-purity electronic chemicals, and strengthened strategic supply chain collaborations with leading multinational pharmaceutical and agrochemical corporations.